{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:54:36Z","timestamp":1779144876610,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4116,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ymthe.2005.02.017","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T09:53:39Z","timestamp":1113904419000},"page":"68-76","source":"Crossref","is-referenced-by-count":27,"title":["IFN-\u03b1 gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes"],"prefix":"10.1016","volume":"12","author":[{"given":"Pedro","family":"Berraondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Crettaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rotellar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1frica","family":"Vales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mart\u00ednez-Ans\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikel","family":"Zaratiegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Gonz\u00e1lez-Aseguinolaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.02.017_bib1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","article-title":"Viral hepatitis B","volume":"362","author":"Lai","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2005.02.017_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2005.02.017_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20110","article-title":"Chronic hepatitis B: update of recommendations","volume":"39","author":"Lok","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2005.02.017_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2003.08.015","article-title":"Pegylated interferons for chronic hepatitis B","volume":"60","author":"Craxi","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ymthe.2005.02.017_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2005.02.017_bib6","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.02.017_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.02.017_bib8","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","article-title":"Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein","volume":"93","author":"Kessler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.02.017_bib9","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1073\/pnas.94.4.1426","article-title":"Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors","volume":"94","author":"Koeberl","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.02.017_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.gt.3300548","article-title":"Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia","volume":"5","author":"Monahan","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.02.017_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-825639","article-title":"Clinical gene transfer studies for hemophilia B","volume":"30","author":"High","year":"2004","journal-title":"Semin. Thromb. Hemostasis"},{"key":"10.1016\/j.ymthe.2005.02.017_bib12","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.02.017_bib13","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1089\/104303401753153956","article-title":"A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease","volume":"12","author":"Aitken","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.02.017_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000150418","article-title":"The woodchuck: an animal model for hepatitis B virus infection in man","volume":"38","author":"Roggendorf","year":"1995","journal-title":"Intervirology"},{"key":"10.1016\/j.ymthe.2005.02.017_bib15","first-page":"131","article-title":"The woodchuck as a model of hepadnavirus infection, pathogenesis and therapy","volume":"6","author":"Cote","year":"1996","journal-title":"Forum Trends Exp. Clin. Med."},{"key":"10.1016\/j.ymthe.2005.02.017_bib16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1128\/JVI.76.4.1769-1780.2002","article-title":"Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation","volume":"76","author":"Menne","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.10221","article-title":"The woodchuck interferon-alpha system: cloning, family description, and biologic activity","volume":"68","author":"Berraondo","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib18","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","article-title":"Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors","volume":"78","author":"Thomas","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib19","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1128\/JVI.78.18.10111-10121.2004","article-title":"Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo","volume":"78","author":"Fiedler","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.02.017_bib21","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2003-11-3845","article-title":"Autoimmune anemia in macaques following erythropoietin gene therapy","volume":"103","author":"Chenuaud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.02.017_bib22","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2003-11-3852","article-title":"Erythropoietin gene therapy leads to autoimmune anemia in macaques","volume":"103","author":"Gao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.02.017_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2005.02.017_bib24","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/JVI.74.10.4816-4823.2000","article-title":"Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis","volume":"74","author":"Aurisicchio","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.gt.3301596","article-title":"Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector","volume":"8","author":"Aurisicchio","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.02.017_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1440-1746.2003.02976.x","article-title":"Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy","volume":"18","author":"Liaw","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2005.02.017_bib27","series-title":"Pegitron: Product Monograph","author":"Anonymous","year":"2002"},{"key":"10.1016\/j.ymthe.2005.02.017_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-0934(96)02121-0","article-title":"Improved production of recombinant AAV by transient transfection of NB324K cells using electroporation","volume":"63","author":"Maxwell","year":"1997","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ymthe.2005.02.017_bib29","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.02.017_bib30","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T06:02:00Z","timestamp":1550124120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1525001605000900"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.02.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}